ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2334

T-Cell Cross Reactivity with Citrullinated Antigen and P. Gingivalis Membrane Antigen Following Infection with P. Gingavalis and/or Injection of Citrullinated Mouse Type II Collagen in DBA/1J Mice

Michael J. Duryee1, Anand Dusad2, Carlos D. Hunter1, Ke Ren3, Dong Wang4, James R. O'Dell5, Lynell W. Klassen5, Ted R. Mikuls6 and Geoffrey M. Thiele7, 1Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, 4Pharmaceutical Sciences, Univ of Nebraska Medical Ctr, Omaha, NE, 5Dept of Internal Medicine, Univ of Nebraska Med Ctr, Omaha, NE, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA) and autoimmune diseases, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recently, periodontal disease (PD) has been associated with the risk and progression of RA.  Patients with RA complicated by PD have been shown to have higher anti-citrullinated protein antibody (ACPA) levels, which have also become predictive markers of the disease and its severity.  Previous studies have demonstrated that RA can be induced in mice following oral infection with P. gingivalis (P. ging), a major cause of PD.  However, these studies never demonstrated antibody or T-cell responses to citrullinated antigens.  Therefore, it was the purpose of this study to determine whether infection with P. ging can induce RA and if these responses induce antibodies and/or T-cell responses to select citrullinated antigens in DBA/1J mice.

Methods: DBA/1J mice were subjected to sulpha-methoxazole in their water for 10 days and then gavaged with P. ging 3 times over a 1 week period. Control mice were subjected to antibiotics in the absence of P. ging and injected with mouse type II collagen collagen (Col).  Also, mice were immunized with citrullinated Col (Cit-Col) in parallel as previously published.  Animals were evaluated weekly for inflammation of the joints for 6 weeks and sacrificed followed by serum and spleen collection.  The CD4+ T cells were then isolated and proliferated against Col, Cit-Col or P. ging outer membrane antigen (PGMA).  Serum was tested for the presence of antibody to PGMA and ACPA, the latter using a second generation anti-CCP assay.

Results: At week 6, mice gavaged with P. ging had a significant increase in inflammation as assessed by paw thickness (2.883 mm) and scoring (3.25) compared to the respective controls (2.543 mm) and (1.6); P≤0.01 between groups.   Similar results were demonstrated for the Cit-Col groups, 2.868 mm and 3.25 (P≤0.001vs. controls).  There was nearly a 2-fold increase in serum ACPA in the P. ging infected mice (11.2 U/ml) compared to no infection (6.89 U/ml) (p=0.002).  The Cit-Col injected animals showed an ACPA response of 10.8 U/ml which was significantly different from controls (P=0.02). Antibody to PGMA was significantly higher in both the P. ging infected animals (4.101 µg/ml) and the Cit-Col (2.714 µg/ml) injected mice compared to controls (1.201 µg/ml) (P≤0.01 for both groups).  CD4+ T-cells from P. ging infected mice proliferated to both Cit-Col (5.34 stimulation index (SI)) and to PGMA (16.68 SI) compared to controls which had SI’s of (0.160) and (0.704) respectively P≤0.001.  T-cells from mice immunized with Cit-Col proliferated to Cit-Col at (3.950 SI) and to PGMA at (4.829 SI).  This proliferative response was not observed with exposure of T-cells from both P.ging or Cit-Col injected mice to P .intermedia (an alternative cause of PD) membrane antigen.    

Conclusion: These data show that following infection with P. ging, DBA/1J mice develop an inflammatory arthritis that is characterized by the expression of ACPA.  Furthermore, T-cells from mice immunized with Cit-Col or infected with P. ging showed increased proliferation to both Cit-Col and PGMA.  This suggests a cross reactivity between the PGMA and the citrullinated antigen.  These studies begin to provide some insight into mechanisms linking P. ging with RA pathogenesis.


Disclosure:

M. J. Duryee,
None;

A. Dusad,
None;

C. D. Hunter,
None;

K. Ren,
None;

D. Wang,
None;

J. R. O’Dell,
None;

L. W. Klassen,
None;

T. R. Mikuls,
None;

G. M. Thiele,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-cell-cross-reactivity-with-citrullinated-antigen-and-p-gingivalis-membrane-antigen-following-infection-with-p-gingavalis-andor-injection-of-citrullinated-mouse-type-ii-collagen-in-dba1j-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology